TCI GENE Inc. (6879.TWO)
TWD 45.7
(3.86%)
TWD 45.7
(3.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 25.98 Million TWD | -78.56% |
| 2022 | 121.16 Million TWD | -22.04% |
| 2021 | 155.42 Million TWD | 180.52% |
| 2020 | 55.4 Million TWD | 0.0% |
| 2019 | 63.01 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 4.8 Million TWD | -25.48% |
| 2024 Q1 | 6.44 Million TWD | 53.29% |
| 2023 Q2 | 3.34 Million TWD | 0.0% |
| 2023 FY | - TWD | -78.56% |
| 2023 Q1 | 3.34 Million TWD | -48.0% |
| 2023 Q4 | 4.2 Million TWD | 0.0% |
| 2023 Q3 | 4.2 Million TWD | 25.62% |
| 2022 Q4 | 6.44 Million TWD | 0.0% |
| 2022 FY | - TWD | -22.04% |
| 2022 Q3 | 6.44 Million TWD | 0.0% |
| 2021 FY | - TWD | 180.52% |
| 2020 FY | - TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 93.399% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 158.072% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 136.027% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 118.081% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 125.075% |
| Visgeneer Inc. | 973 Thousand TWD | -2570.195% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 97.226% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 73.977% |
| Neith Corporation | -33.61 Million TWD | 177.301% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 1595.74% |
| Enimmune corporation | -228.96 Million TWD | 111.347% |
| TaiRx, Inc. | -208.64 Million TWD | 112.452% |
| EirGenix Inc. | -664.4 Million TWD | 103.91% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 64.845% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 62.424% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 122.97% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 25.423% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 198.787% |
| RBC Bioscience Corporation | 36.54 Million TWD | 28.911% |
| BiOptic Inc. | 65.03 Million TWD | 60.053% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 156.182% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 178.716% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 147.311% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 94.007% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 107.653% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 102.621% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 141.676% |
| Level Biotechnology Inc. | 98.7 Million TWD | 73.678% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 202.964% |
| GlycoNex Incorporation | -126.82 Million TWD | 120.485% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -19.124% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 246.57% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 102.425% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 103.807% |
| VBI | -6.97 Million TWD | 472.648% |
| CHO Pharma, Inc. | -277.73 Million TWD | 109.355% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 132.447% |
| NaviFUS Corp. | -55.79 Million TWD | 146.565% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 256.531% |
| Sinew Pharma Inc. | -163.63 Million TWD | 115.878% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 142.246% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 86.497% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 111.462% |
| AP Biosciences Inc | -325.51 Million TWD | 107.982% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 102.487% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 172.479% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 10.81% |
| Intech Biopharm Corporation | -219.58 Million TWD | 111.832% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 103.853% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 157.798% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 116.152% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 96.037% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 123.483% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 109.155% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 117.799% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -87.588% |
| PharmaEngine, Inc. | 347.3 Million TWD | 92.519% |
| Savior Lifetec Corporation | 219.6 Million TWD | 88.169% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 84.915% |
| OBI Pharma, Inc. | -855.08 Million TWD | 103.038% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 128.068% |
| Acepodia, Inc. | -764.51 Million TWD | 103.398% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 105.647% |